Skip to main content

Advertisement

SpringerLink
Log in

Treatment of Peyronie’s Disease: 2012 Update

  • Erectile Dysfunction (Thomas Lue, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Peyronie’s disease (PD) is the occurrence of a fibrous inelastic scar of the tunica albuginea of the penis. It is a relatively common disorder among men, with a reported prevalence of 3% to 8%. It is often associated with penile pain, anatomical deformities in the erect state, and difficulty with intromission. Because the exact pathophysiology of PD remains unknown and standards for evaluating or reporting treatment outcomes are unclear, research on effective therapies has been limited. The benefits of nonsurgical treatment options are conflicting and further controlled studies are required before any therapy can be fully recommended. The success of surgery has been well documented; however, surgery is invasive and costly and carries potential side effects. Patients who report stable disease that has been present for longer than 12 months and who experience penile deformity preventing satisfactory sexual intercourse are best suited for surgery. Additionally, failed conservative management and a patient’s preference for definitive correction are important additional indications for surgical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, Levine L. The management of Peyronie's disease: evidence-based 2010 guidelines. J Sex Med. 2010;7(7):2359–74. This recent guideline summarizes the treatment options for PD.

    PubMed  Google Scholar 

  2. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: results of a large survey. BJU Int. 2001;88:727–30.

    Article  PubMed  CAS  Google Scholar 

  3. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, et al. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171:2350–3.

    Article  PubMed  Google Scholar 

  4. Williams JL, Thomas GG. The natural history of Peyronie’s disease. J Urol. 1970;103(1):75–6.

    PubMed  CAS  Google Scholar 

  5. •• Hellstrom WJ. Medical management of Peyronie’s disease. J Androl. 2009;30(4):397–405. This is a very important guideline that highlights the medical treatment for PD.

    Article  PubMed  CAS  Google Scholar 

  6. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie’s disease. J Urol. 2002;68:1075–9.

    Google Scholar 

  7. Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie’s disease. J Urol. 2006;175:2115–8.

    Article  PubMed  Google Scholar 

  8. Hellstrom WJ, Bivalacqua TJ. Peyronie’s disease: etiology, medical, and surgical therapy. J Androl. 2000;21(3):347–54.

    PubMed  CAS  Google Scholar 

  9. Ahuja SK, Sikka SC, Hellstrom WJ. Stimulation of collagen production in an in vitro model for Peyronie’s disease. Int J Impot Res. 1999;11(4):207–12.

    Article  PubMed  CAS  Google Scholar 

  10. Pryor JP, Farell CR. Controlled clinical trial of vitamin E in Peyronie’s disease. Prog Reprod Biol Med. 1983;9:41–5.

    Google Scholar 

  11. Safarinejad MR, Hosseini SY, Kolahi AA. Comparison of vitamin E and propionyl-Lcarnitine, separately or in combination, in patients with early chronic Peyronie’s disease: a double-blind, placebo controlled, randomized study. J Urol. 2007;178:1398–403.

    Article  PubMed  CAS  Google Scholar 

  12. Shindel AW, Bullock TL, Brandes S. Urologist practice patterns in the management of Peyronie’s disease: a nationwide survey. J Sex Med. 2008;5:954–64.

    Article  PubMed  Google Scholar 

  13. Zarafonetis CJD, Horrax TM. Treatment of Peyronie’s disease with potassium paraaminobenzoate (Potaba). J Urol. 1959;81:770–2.

    PubMed  CAS  Google Scholar 

  14. Shah PJR, Green NA, Adib RS, Pryor JP. A multicentre double-blind controlled clinical trial of potassium-paraaminobenzoate (Potaba) in Peyronie’s disease. Prog Reprod Biol Med. 1983;9:61–7.

    Google Scholar 

  15. Weidner W, Hauck EW, Schnitker J. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie’s disease: a prospective, placebo-controlled, randomized study. Eur Urol. 2005;47:530–6.

    Article  PubMed  CAS  Google Scholar 

  16. Akkus E, Carrier S, Rehman J, Breza J, Kadioglu A, Lue TF. Is colchicine effective in Peyronie’s disease? A pilot study. Urology. 1994;44:291–5.

    Article  PubMed  CAS  Google Scholar 

  17. Kadioglu A, Tefekli A, Köksal T, Usta M, Erol H. Treatment of Peyronie’s disease with oral colchicine: long-term results and predictive parameters of successful outcome. Int J Impot Res. 2000;12:169–75.

    Article  PubMed  CAS  Google Scholar 

  18. Safarinejad MR. Therapeutic effects of colchicine in the management of Peyronie’s disease: a randomized double-blind, placebo-controlled study. Int J Impot Res. 2004;16:238–43.

    Article  PubMed  CAS  Google Scholar 

  19. Prieto Castro RM, Leva Vallejo ME, Regueiro Lopez JC, Anglada Curado FJ, Alvarez Kindelan J, Requena Tapia MJ. Combined treatment with vitamin E and colchicine in the early stages of Peyronie’s disease. BJU Int. 2003;91:522–4.

    Article  PubMed  CAS  Google Scholar 

  20. Ralph DJ, Brooks MD, Bottazzo GF, Pryor JP. The treatment of Peyronie’s disease with tamoxifen. Br J Urol. 1992;70:648–51.

    Article  PubMed  CAS  Google Scholar 

  21. Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA. Tamoxifen versus placebo in the treatment of Peyronie’s disease. J Urol. 1999;162:2003–5.

    Article  PubMed  CAS  Google Scholar 

  22. Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie’s disease: a preliminary report. BJU Int. 2001;88:63–7.

    Article  PubMed  CAS  Google Scholar 

  23. Cavallini G, Biagiotti G, Koverech A, Vitali G. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie’s disease. BJU Int. 2002;89:895–900.

    Article  PubMed  CAS  Google Scholar 

  24. Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-Arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie’s fibrotic plaque and related fibroblast cultures. Nitric Oxide. 2003;9:229–44.

    Article  PubMed  CAS  Google Scholar 

  25. Brant WO, Dean RC, Lue TF. Treatment of Peyronie’s disease with oral pentoxifylline. Nat Clin Pract Urol. 2006;3:111–5.

    Article  PubMed  Google Scholar 

  26. •• Smith JF, Shindel AW, Huang YC, Clavijo RI, Flechner L, Breyer BN, Eisenberg ML, Lue TF. Pentoxifylline treatment and penile calcifications in men with Peyronie's disease. Asian J Anrol. 2011;13(2):322–5. This is an interesting article providing data regarding the beneficial effect of pentoxifylline in the treatment of PD.

    Article  CAS  Google Scholar 

  27. Shindel AW, Lin G, Ning H, Banie L, Huang YC, Liu G, et al. Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. J Sex Med. 2010;7(6):2077–85.

    PubMed  CAS  Google Scholar 

  28. Shindel AW, Lin G, Ning H, Banie L, Huang YC, Liu G, et al. Pentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts part 2: interference in a TGF-beta1/Smad-dependent mechanism and downregulation of AAT1. J Sex Med. 2010;7(5):1787–97.

    Article  PubMed  CAS  Google Scholar 

  29. Safarinejad MR, Asgari MA, Hosseini SY, Dadkhah F. A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie’s disease. BJU Int. 2010;106(2):240–8.

    Article  PubMed  CAS  Google Scholar 

  30. Chung E, Deyoung L, Brock GB. The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med. 2011;8(5):1472–7.

    Article  PubMed  CAS  Google Scholar 

  31. Bodner H, Howard AH, Kaplan JH. Peyronie’s disease: cortisone hyaluronidase-hydrocortisone therapy. J Urol. 1954;400–3.

  32. Winter CC, Khanna R. Peyronie’s disease: results with dermojet injection of dexamethasone. J Urol. 1975;114:898–900.

    PubMed  CAS  Google Scholar 

  33. Williams G, Green NA. The non-surgical treatment of Peyronie’s disease. Br J Urol. 1980;52:392–5.

    Article  PubMed  CAS  Google Scholar 

  34. Gelbard MK, Walsh R, Kaufman JJ. Collagenase for Peyronie’s disease experimental studies. Urol Res. 1982;10:135–40.

    Article  PubMed  CAS  Google Scholar 

  35. Gelbard MK, Linkner A, Kaufman JJ. The use of collagenase in the treatment of Peyronie’s disease. J Urol. 1985;134:280–3.

    PubMed  CAS  Google Scholar 

  36. Gelbard MK, James K, Riach P, Dorey F. Collagenase vs. Placebo in the treatment of Peyronie’s disease: a double blind study. J Urol. 1993;149:56–8.

    PubMed  CAS  Google Scholar 

  37. Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie’s disease: a prospective, single-center, non-placebo controlled study. J Sex Med. 2008;5:180–7.

    Article  PubMed  Google Scholar 

  38. Roth M, Eickelberg O, Kohler E, Erne P, Block LH. Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci USA. 1996;93:5478–82.

    Article  PubMed  CAS  Google Scholar 

  39. Levine LA, Merrick PF, Lee RC. Intralesional verapamil injection for the treatment of Peyronie’s disease. J Urol. 1994;151:1522–4.

    PubMed  CAS  Google Scholar 

  40. Rehman J, Benet A, Melman A. Use of intralesional verapamil to dissolve Peyronie’s disease plaque: a long-term single-blind study. Urology. 1998;51:620–6.

    Article  PubMed  CAS  Google Scholar 

  41. Bennett NE, Guhring P, Mulhall JP. Intralesional verapamil prevents the progression of Peyronie’s disease. Urology. 2007;69:1181–4.

    Article  PubMed  Google Scholar 

  42. Cavallini G, Modenini F, Vitali G. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie’s disease. Urology. 2007;69:950–4.

    Article  PubMed  Google Scholar 

  43. •• Soh J, Kawauchi A, Kanemitsu N, Naya Y, Ochiai A, Naitoh Y, Fujiwara T, Kamoi K, Miki T. Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial. J Sex Med. 2010;7(11):3743–9. This prospective controlled study provides evidence for the beneficial effect of intralesional nicardipine injection treatment.

    Article  PubMed  CAS  Google Scholar 

  44. Duncan MR, Berman B, Nseyo UO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie’s disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol. 1991;25(2):89–94.

    Article  PubMed  CAS  Google Scholar 

  45. Judge IS, Wisniewski ZS. Intralesional interferon in the treatment of Peyronie’s disease: a pilot study. Br J Urol. 1997;79(1):40–2.

    Article  PubMed  CAS  Google Scholar 

  46. Polat O, Gul O, Ozbey I, Ozdikici M, Bayraktar Y. Peyronie’s disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging. Int Urol Nephrol. 1997;29(4):465–71.

    Article  PubMed  CAS  Google Scholar 

  47. Hellstrom WJ, Kendirci M, Matern R, Cockerham Y, Myers L, Sikka SC, et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie’s disease. J Urol. 2006;176(1):394–8.

    Article  PubMed  CAS  Google Scholar 

  48. Inal T, Tokatli Z, Akand M, Ozdiler E, Yaman O. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie’s disease: a randomized and prospective study. Urology. 2006;67:1038–42.

    Article  PubMed  Google Scholar 

  49. Gelbard M, Lindner A, Chvapil M, Kaufman J. Topical betaaminopropionitrile in the treatment of Peyronie’s disease. J Urol. 1983;129(4):746–8.

    PubMed  CAS  Google Scholar 

  50. Miller HC, Ardizzone J. Peyronie disease treated with ultrasound and hydrocortisone. Urology. 1983;21(6):584–5.

    Article  PubMed  CAS  Google Scholar 

  51. Martin DJ, Badwan K, Parker M, Mulhall JP. Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. J Urol. 2002;168(6):2483–5.

    Article  PubMed  CAS  Google Scholar 

  52. Fitch WP, Easterling J, Talbert RL, Bordovsky MJ, Mosier M. Topical verapamil HCI, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie’s disease—a placebo-controlled pilot study. J Sex Med. 2007;4(2):477–84.

    Article  PubMed  CAS  Google Scholar 

  53. Riedl CR, Plas E, Engelhardt P, Daha K, Pflüger H. Iontophoresis for treatment of Peyronie’s disease. J Urol. 2000;163:95–9.

    Article  PubMed  CAS  Google Scholar 

  54. Di Stasi S, Giannantoni A, Stephen RL, Capelli G, Giurioli A, Jannini EA, et al. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease. J Urol. 2004;171:1605–8.

    Article  PubMed  CAS  Google Scholar 

  55. Di Stasi SM, Giannantoni A, Capelli G, Jannini EA, Vigili G, Storti L, et al. Transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease. BJU Int. 2003;91(9):825–9.

    Article  PubMed  CAS  Google Scholar 

  56. Greenfield JM, Shah SJ, Levine LA. Verapamil versus saline in electromotive drug administration for Peyronie’s disease: a double-blind, placebo controlled trial. J Urol. 2007;177:972–5.

    Article  PubMed  CAS  Google Scholar 

  57. Skolarikos A, Alargof E, Rigas A, Deliveliotis Ch, Konstantinidis E. Shockwave therapy as first-line treatment for Peyronie’s disease: a prospective study. J Endourol. 2005;19(1):11–4.

    Article  PubMed  CAS  Google Scholar 

  58. Srirangam SJ, Manikandan R, Hussain J, Collins GN, O’Reilly PH. Long-term results of extracorporeal shockwave therapy for Peyronie’s disease. J Endourol. 2006;20:880–4.

    Article  PubMed  Google Scholar 

  59. Michel MS, Ptaschnyk T, Musial A, Braun P, Lenz ST, Alken P, et al. Objective and subjective changes in patients with Peyronie’s disease after management with shock wave therapy. J Endourol. 2003;17:41–4.

    Article  PubMed  Google Scholar 

  60. Strebel RT, Suter S, Sautter T, Hauri D. Extracorporeal shock wave therapy for Peyronie’s disease does not correct penile deformity. Int J Impot Res. 2004;16:448–51.

    Article  PubMed  CAS  Google Scholar 

  61. Hauck EW, Hauptmann A, Bschleipfer T, Schmelz HU, Altinkilic BM, Weidner W. Questionable efficacy of extracorporeal shock wave therapy in Peyronie’s disease: results of a prospective approach. J Urol. 2004;171:269–99.

    Google Scholar 

  62. Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W. Extracorporeal shock wave therapy for Peyronie’s disease: exploratory meta-analysis of clinical trials. J Urol. 2004;171:740–5.

    Article  PubMed  Google Scholar 

  63. •• Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, Creta M, Mirone V. A first prospective, randomized, double-blind, placebo- controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol. 2009;56:363–70. This was the first prospective, randomized, controlled trial that brought up ESWL as a treatment option for PD.

    Article  PubMed  Google Scholar 

  64. Chitale S, Morsey M, Swift L, Sethia K. Limited shock wave therapy vs sham treatment in men with Peyronie’s disease: results of a prospective randomized controlled double-blind trial. BJU Int. 2010;106(9):1352–6.

    Article  PubMed  Google Scholar 

  65. Taylor FL, Levine LA. Non-surgical therapy of Peyronie’s disease. Asian J Androl. 2008;10(1):79–87.

    Article  PubMed  CAS  Google Scholar 

  66. Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie’s disease: a single-center pilot study. J Sex Med. 2008;5:1468–73.

    Article  PubMed  Google Scholar 

  67. Gontero P, Di Marco M, Giubilei G, Bartoletti R, Pappagallo G, Tizzani A, et al. Use of penile extender device in the treatment of penile curvature as a result of Peyronie’s disease. Results of a phase ii prospective study. J Sex Med. 2009;6:559–66.

    Article  Google Scholar 

  68. Raheem AA, Garaffa G, Raheem TA, Dixon M, Kayes A, Christopher N, et al. The role of vacuum pump therapy to mechanically straighten the penis in Peyronie’s disease. BJU Int. 2010;106(8):1178–80.

    Article  PubMed  Google Scholar 

  69. Kendirci M, Hellstrom WJ. Critical analysis of surgery for Peyronie’s disease. Curr Opin Urol. 2004;6:381–8.

    Article  Google Scholar 

  70. Dimitriou R, Levine LA. A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie’s Disease. J Urol. 1999;161:1014A.

    Google Scholar 

  71. Levine LA, Lenting E. A surgical algorithm for the treatment of Peyronie’s disease. J Urol. 1997;158:2149–52.

    Article  PubMed  CAS  Google Scholar 

  72. Mulhall JP, Anderson M, Parker M. A surgical algorithm for men with combined Peyronie’s disease and erectile dysfunction: functional and satisfaction outcomes. J Sex Med. 2005;2:132–8.

    Article  PubMed  Google Scholar 

  73. Ralph DJ, Minhas S. The management of Peyronie’s disease. BJU Int. 2004;93:208–15.

    Article  PubMed  CAS  Google Scholar 

  74. • Kadioglu A, Kucukdurmaz F, Sanli O. Current status of the surgical management of Peyronie's disease. Nat Rev Urol. 2011;8(2):95–106. This is a recent review of surgical treatment modalities for PD.

    Article  PubMed  Google Scholar 

  75. Nesbit RM. Congenital curvature of the phallus: report of three cases with description of corrective operation. J Urol. 1965;93:230–2.

    PubMed  CAS  Google Scholar 

  76. Pryor JP, Fitzpatrick JM. A new approach to the correction of the penile deformity in Peyronie’s disease. J Urol. 1979;122(5):622–3.

    PubMed  CAS  Google Scholar 

  77. Savoca G, Scieri F, Pietropaolo F, Garaffa G, Belgrano E. Straightening corporoplasty for Peyronie’s disease: a review of 218 patients with median follow-up of 89 months. Eur Urol. 2004;46:610–4.

    Article  PubMed  Google Scholar 

  78. Bokarica P, Parazajder J, Mazuran B, Gilja I. Surgical treatment of Peyronie’s disease based on penile length and degree of curvature. Int J Impot Res. 2005;17:170–4.

    Article  PubMed  CAS  Google Scholar 

  79. Licht MR, Lewis RW. Modified Nesbit procedure for the treatment of Peyronie’s disease: a comparative outcome analysis. J Urol. 1997;158:4603.

    Article  Google Scholar 

  80. Ralph DJ, al-Akraa M, Pryor JP. The Nesbit operation for Peyronie’s disease: 16-year experience. J Urol. 1995;154:1362–3.

    Article  PubMed  CAS  Google Scholar 

  81. Rolle L, Tamagnone A, Timpano M, Destefanis P, Fiori C, Ceruti C, et al. The Nesbit operation for penile curvature: an easy and effective technical modification. J Urol. 2005;173:171–3.

    Article  PubMed  Google Scholar 

  82. Syed AH, Abbasi Z, Hargreave TB. Nesbit procedure for disabling Peyronie’s curvature: a median follow-up of 84 months. Urology. 2003;61:999–1003.

    Article  PubMed  Google Scholar 

  83. Yachia D. Modified corporoplasty for the treatment of penile curvature. J Urol. 1990;143:80–2.

    PubMed  CAS  Google Scholar 

  84. Essed E, Schroeder F. New surgical technique for Peyronie’s disease. Urology. 1985;25:582–7.

    Article  PubMed  CAS  Google Scholar 

  85. Daitch JA, Angermeier KW, Montague DK. Modified corporoplasty for penile curvature: long-term results and patient satisfaction. J Urol. 1999;162:2006–9.

    Article  PubMed  CAS  Google Scholar 

  86. Rehman J, Benet A, Minsky LS, Melman A. Results of surgical treatment for abnormal penile curvature: Peyronie’s disease and congenital deviation by modified Nesbit plication (tunical shaving and plication). J Urol. 1997;157:1288–91.

    Article  PubMed  CAS  Google Scholar 

  87. Van Der Horst C, Martinez Portillo FJ, Seif C, Alken P, Juenemann KP. Treatment of penile curvature with Essed-Schroder tunical plication: aspects of quality of life from the patients’ perspective. BJU Int. 2004;93:105–8.

    Article  Google Scholar 

  88. Greenfield JM, Lucas S, Levine LA. Factors affecting the loss of length associated with tunica albuginea plication for correction of penile curvature. J Urol. 2006;175:238–41.

    Article  PubMed  Google Scholar 

  89. Taylor FL, Levine LA. Surgical correction of Peyronie’s disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow-up. J Sex Med. 2008;5:2221–8.

    Article  PubMed  Google Scholar 

  90. Gholami SS, Lue TF. Correction of penile curvature using the 16‑dot plication technique: a review of 132 patients. J Urol. 2002;167:2066–9.

    Article  PubMed  Google Scholar 

  91. Dugi DD, Morey AF. Penoscrotal plication as a uniform approach to reconstruction of penile curvature. BJU Int. 2010;105:1440–4.

    Article  PubMed  Google Scholar 

  92. Kadioglu A, Sanli O, Akman T, Cakan M, Erol B, Mamadov F. Surgical treatment of Peyronie’s disease: a single center experience with 145 patients. Eur Urol. 2008;53:432–9.

    Article  PubMed  Google Scholar 

  93. Kovac JR, Brock GB. Surgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie’s disease. J Sex Med. 2007;4:1500–8.

    Article  PubMed  Google Scholar 

  94. Lowsley OS, Boyce WH. Further experiences with an operation for the cure of Peyronie’s disease. J Urol. 1950;63:888–902.

    PubMed  CAS  Google Scholar 

  95. Gelbard MK, Hayden B. Expanding contractures of the tunica albuginea due to Peyronie’s disease with temporalis fascia free grafts. J Urol. 1991;145:772–6.

    PubMed  CAS  Google Scholar 

  96. Shioshvili TJ, Kakonashvili AP. The surgical treatment of Peyronie’s disease: replacement of plaque by free autograft of buccal mucosa. Eur Urol. 2005;48:129–33.

    Article  PubMed  Google Scholar 

  97. Cormio L, Zucchi A, Lorusso F, Selvaggio O, Figretti F, Porena M, et al. Surgical treatment of Peyronie’s disease by plaque incision and grafting with buccal mucosa. Eur Urol. 2009;55:146975.

    Google Scholar 

  98. Dublin N, Stewart LH. Oral complications after buccal mucosal graft harvest for urethroplasty. BJU Int. 2004;94:867–9.

    Article  PubMed  Google Scholar 

  99. Hsu YS, Huang WJ, Kuo JY, Chung HJ, Chen KK, Chang LS. Experience of surgical treatment of Peyronie’s disease with deep dorsal venous patch in Taiwanese men. J Chin Med Assoc. 2003;66:487–91.

    PubMed  Google Scholar 

  100. Brock G, Kadioglu A, Lue TF. Peyronie’s disease: a modified treatment. Urology. 1993;42:300–4.

    Article  PubMed  CAS  Google Scholar 

  101. El-Sakka AI, Rashwan HM, Lue TF. Venous patch graft for Peyronie’s disease. Part II: outcome analysis. J Urol. 1998;160:2050–3.

    Article  PubMed  CAS  Google Scholar 

  102. Kalsi J, Minhas S, Christopher N, Ralph D. The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie’s disease. BJU Int. 2005;95:1029–33.

    Article  PubMed  Google Scholar 

  103. Radopoulos D, Vakalopoulos I, Thanos P. Preputial graft in penile curvature correction: preliminary results. Int J Impot Res. 2009;21:82–7.

    Article  PubMed  CAS  Google Scholar 

  104. Wild RM, Devine CJ, Horton CE. Dermal graft repair of Peyronie’s disease: survey of 50 patients. J Urol. 1979;121:47–50.

    PubMed  CAS  Google Scholar 

  105. Goyal NK, Kumar A, Das SK, Pandey AK, Sharma GK, Trivedi S, et al. Experience with plaque excision and dermal grafting in the surgical treatment of Peyronie’s disease. Singapore Med J. 2008;49:805–8.

    PubMed  CAS  Google Scholar 

  106. Krishnamurti S. Penile dermal flap for defect reconstruction in Peyronie’s disease: operative technique and four years’ experience in 17 patients. Int J Impot Res. 1995;7:195–208.

    PubMed  CAS  Google Scholar 

  107. Teloken C, Grazziotin T, Rhoden E, Da Ros C, Fornari A, Soares FC, et al. Penile straightening with crural graft of the corpus cavernosum. J Urol. 2000;164:107–8.

    Article  PubMed  CAS  Google Scholar 

  108. Schwarzer JU, Mühlen B, Schukai O. Penile corporoplasty using tunica albuginea free graft from proximal corpus cavernosum: a new technique for treatment of penile curvature in Peyronie’s disease. Eur Urol. 2003;44(6):720–3.

    Article  PubMed  Google Scholar 

  109. Hatzichristou DG, Hatzimouratidis K, Apostolidis A, Tzortzis V, Bekos A, Ioannidis E. Corporoplasty using tunica albuginea free grafts for penile curvature: surgical technique and long-term results. J Urol. 2002;167:1367–70.

    Article  PubMed  Google Scholar 

  110. O’Donnell PD. Results of surgical management of Peyronie’s disease. J Urol. 1992;148:1184–7.

    PubMed  Google Scholar 

  111. Kargi E, Yesilli C, Hosnuter M, Akduman B, Babuccu O, Mungan A. Relaxation incision and fascia lata grafting in the surgical correction of penile curvature in Peyronie’s disease. Plast Reconstr Surg. 2004;113:254–9.

    Article  PubMed  Google Scholar 

  112. Craatz S, Spanel-Boroeki K, Begemann JF, Olianas R, Fisch M, Hohenfellner R. The dorsal lamina of rectus sheath. a suitable grafting material for the penile tunica albuginea in Peyronie’s disease? BJU Int. 2006;97:134–7.

    Article  PubMed  Google Scholar 

  113. Chang JA, Gholami SS, Lue TF. Saphenous vein grafts. Int J Impot Res. 2002;14:375–8.

    Article  PubMed  CAS  Google Scholar 

  114. Adeniyi AA, Goorney SR, Pryor JP, Ralph DJ. The Lue procedure: an analysis of the outcome in Peyronie’s disease. BJU Int. 2002;89:404–8.

    Article  PubMed  CAS  Google Scholar 

  115. Akkus E, Ozkara H, Alici B, Demirkesen O, Akaydin A, Hattat H, et al. Incision and venous patch graft in the surgical treatment of penile curvature in Peyronie’s disease. Eur Urol. 2001;40:531–6.

    Article  PubMed  CAS  Google Scholar 

  116. De Stefani S, Savoca G, Ciampalini S, Gattuccio I, Scieri F, Belgrano E. Saphenous vein harvesting by ‘stripping’ technique and ‘W’-shaped patch covering after plaque incision in the treatment of Peyronie’s disease. Int J Impot Res. 2000;12:299–301.

    Article  PubMed  Google Scholar 

  117. Montorsi, F. et al. Five year follow-up of plaque incision and vein grafting for Peyronie’s disease [abstract 123]. Eur Urol. 2004;Suppl 3: 33.

    Google Scholar 

  118. Kadioglu A, Sanli O, Akman T, Ersay A, Guven S, Mammadov F. Graft materials in Peyronie’s disease surgery: a comprehensive review. J Sex Med. 2007;4:581–95.

    Article  PubMed  Google Scholar 

  119. Brannigan RE, Kim ED, Oyasu R, McVary KT. Comparison of tunica albuginea substitute for the treatment of Peyronie’s disease. J Urol. 1998;159:1064–8.

    Article  PubMed  CAS  Google Scholar 

  120. Taylor FL, Levine LA. Surgical correction of Peyronie’s disease using Tunica albuginea plication or partial plaque excision with pericardial graft: long-term followup. J Sex Med. 2008;5:2221–8.

    Article  PubMed  Google Scholar 

  121. Levine LA, Estrada CR. Human cadaveric pericardial graft for the surgical correction of Peyronie’s disease. J Urol. 2003;170:2359–62.

    Article  PubMed  Google Scholar 

  122. Chun JL, McGregor A, Krishnan R, Carson CC. A comparison of dermal and cadaveric pericardial grafts in the modified Horton-Devine procedure for Peyronie’s disease. J Urol. 2001;166:185–8.

    Article  PubMed  CAS  Google Scholar 

  123. Usta MF, Bivalacqua TJ, Sanabria J, Koksal IT, Moparty K, Hellstrom WJ. Patient and partner satisfaction and long-term results after surgical treatment for Peyronie’s disease. Urology. 2003;62:105–9.

    Article  PubMed  Google Scholar 

  124. Edygio PH, Lucon AM, Arap S. Treatment of Peyronie’s disease by incomplete circumferential incision of the tunica albuginea and plaque with bovine pericardium graft. Urology. 2002;59:570–4.

    Article  Google Scholar 

  125. Breyer BN, Brant WO, Garcia MM, Bella AJ, Lue TF. Complications of porcine small intestine submucosa graft for Peyronie’s disease. J Urol. 2007;177:589–91.

    Article  PubMed  Google Scholar 

  126. Knoll LD. Use of small intestinal submucosa graft for the surgical management of Peyronie’s disease. J Urol. 2007;178:2474–8.

    Article  PubMed  Google Scholar 

  127. Lee EW, Shindel AW, Brandes SB. Small intestinal submucosa for patch grafting after plaque incision in the treatment of Peyronie’s disease. Int Braz J Urol. 2008;34:191–6.

    Article  PubMed  Google Scholar 

  128. Kalsi JS, Christopher N, Ralph DJ, Minhas S. Plaque incision and fascia lata grafting in the surgical management of Peyronie’s disease. BJU Int. 2006;98:110–4.

    Article  PubMed  Google Scholar 

  129. Sampaio JS, Fonseca J, Passarinho A, Cristino J, Mendes J. Peyronie’s disease: surgical correction of 40 patients with relaxing incision and duramater graft. Eur Urol. 2002;41:551–5.

    Article  PubMed  CAS  Google Scholar 

  130. Kovac JR, Brock GB. Surgical outcomes and patient satisfaction after dermal, pericardial and small intestinal submucosal grafting for Peyronie’s disease. J Sex Med. 2007;4:1500–8.

    Article  PubMed  Google Scholar 

  131. Montorsi F, Guazzoni G, Bergamaschi F, Rigatti P. Patient-partner satisfaction with semirigid penile prostheses for Peyronie’s disease: a 5‑year followup study. J Urol. 1993;150:1819–21.

    PubMed  CAS  Google Scholar 

  132. Wilson SK, Delk JR. A new treatment for Peyronie’s disease: modeling the penis over an inflatable penile prosthesis. J Urol. 1994;152:1121–3.

    PubMed  CAS  Google Scholar 

  133. Levine LA, Dimitriou RJ. A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie’s disease. Int J Impot Res. 2000;12:147–51.

    Article  PubMed  CAS  Google Scholar 

  134. Carson CC. Penile prothesis implantation in the treatment of Peyronie’s disease and erectile dysfunction. Int J Impot Res. 2000;12 Suppl 4:S122–6.

    Article  PubMed  Google Scholar 

  135. Chaudhary M, Sheikh N, Asterling S, Ahmad I, Greene D. Peyronie’s disease with erectile dysfunction: penile modeling over inflatable penile prostheses. Urology. 2005;65:760–4.

    Article  PubMed  CAS  Google Scholar 

  136. Levine LA, Benson J, Hoover C. Inflatable penile prosthesis placement in men with Peyronie’s disease and drug-resistant erectile dysfunction: a single-center study. J Sex Med. 2010;7:3775–83.

    Article  PubMed  Google Scholar 

  137. Rahman NU, Carrion RE, Bochinski D, Lue TF. Combined penile placation surgery and insertion of penile prosthesis for severe penile curvature and erectile dysfunction. J Urol. 2004;171:2346–9.

    Article  PubMed  Google Scholar 

Download references

Disclosures

E. C. Serefoglu: none. Dr. Wayne J. G. Hellstrom has received honoraria from Auxilium Pharmaceuticals, Cook Medical, and Coloplast.

Author information

Authors and Affiliations

  1. Department of Urology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-42, New Orleans, LA, 70112, USA

    Ege Can Serefoglu & Wayne J. G. Hellstrom

Authors
  1. Ege Can Serefoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wayne J. G. Hellstrom
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wayne J. G. Hellstrom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serefoglu, E.C., Hellstrom, W.J.G. Treatment of Peyronie’s Disease: 2012 Update. Curr Urol Rep 12, 444–452 (2011). https://doi.org/10.1007/s11934-011-0212-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-011-0212-2

Keywords

Search

Navigation